Citation

Konrad-Bindl DS, Gresser U, Richartz BM. Neuropsychiatr. Dis. Treat. 2016; 12: 2635-2647.

Copyright

(Copyright © 2016, Dove Press)

DOI

10.2147/NDT.S114185

PMID

unavailable

Abstract

BACKGROUND: Our review of the scientific literature focused on an analysis of studies describing instances of methylphenidate treatment leading (or not) to behavioral changes in the pediatric, adolescent, and adult populations.

MATERIALS AND METHODS: We conducted a literature search in PubMed, Medline, and Google using the keywords "methylphenidate", "behavioral changes", "adverse effects", and "side effects". A total of 44 studies were identified as reporting on the effects and adverse effects of methylphenidate administration, and were included in the analysis.

RESULTS: Five studies specifically set out to study, record, and discuss changes in behavior. Eight studies did not set out to study behavioral effects, but record and discuss them. A total of 28 studies recorded behavioral effects, but failed to discuss these further. Three studies did not include behavioral effects.

CONCLUSION: This review records what data have been published in respect of changes in behavior in association with the use of methylphenidate. While there is some evidence to suggest that methylphenidate causes changes in behavior, the majority of the studies reviewed paid little or no attention to this issue. Based on the available data, it is impossible to determine the point at which such behavioral effects occur. The frequency of occurrence of behavioral effects is also impossible to determine with certainty. Based on the available data, it is not possible to rule out whether behavioral effects may persist or not persist once treatment is discontinued. In conclusion, despite countless publications and extensive administration, especially to children, we have insufficient data to judge the long-term effects and risks of methylphenidate taking. © 2016 Konrad-Bindl et al.

Language: en

Keywords

Adults; human; Children; Review; depression; aggression; anxiety; behavior change; drug use; suicide attempt; risk assessment; morbidity; Adverse effects; Methylphenidate; disease classification; hallucination; paranoia; drowsiness; placebo; seizure; follow up; drug withdrawal; irritability; nightmare; mania; side effect; attention deficit disorder; agitation; methylphenidate; mental instability; nervousness; dizziness; euphoria; drug exposure; hyperactivity; tic; Attention-deficit/hyperactivity disorder; funding; randomized controlled trial (topic); habit; sadness; Changes in behavior